J7508 HCPCS code: Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
J7508 is the HCPCS Level II code for tacrolimus, extended release, (astagraf xl), oral, 0.1 mg. In 2024 Medicare paid an average of $0.43 per service for J7508 across 4,826,455 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 9000 per day on DME suppliers. Medicare volume fell 32% from 2022 to 2024 (7,063,645 to 4,826,455 services). In 2024, 286 suppliers billed Medicare for J7508 (purchases), serving 477 beneficiaries; New York, Maryland, Illinois accounted for 38% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2014-01-01 |
| Last action effective | 2018-01-01 |
Who bills J7508 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 286 |
| Referring clinicians | 425 |
| Medicare beneficiaries | 477 |
| States with claims | 43 |
| Share of services in top 3 states (New York, Maryland, Illinois) | 38% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 337 | 738 |
| 2023 | 302 | 535 |
| 2024 | 286 | 477 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7508, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 7,063,645 | 738 | $0.51 | $0.39 |
| 2023 | 5,821,325 | 535 | $0.54 | $0.41 |
| 2024 | 4,826,455 | 477 | $0.56 | $0.43 |
States with the most J7508 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 778,530 | $0.43 |
| Maryland | 518,100 | $0.42 |
| Illinois | 509,510 | $0.42 |
| New Jersey | 338,775 | $0.43 |
| California | 301,320 | $0.43 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 9000 | Prescribing Information |
| outpatient hospital claims | 300 | Prescribing Information |
What changed for J7508
- 2014-01-01: J7508 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7508?
J7508 is the HCPCS Level II code for tacrolimus, extended release, (astagraf xl), oral, 0.1 mg. Short descriptor: "Tacrol astagraf ex rel oral".
How much does Medicare pay for J7508?
In 2024, the average Medicare payment was $0.43 per service (average allowed $0.56).
Does Medicare cover J7508?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J7508 can be billed per day?
9000 on DME suppliers; 300 on outpatient hospital claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7502 — Cyclosporine, oral, 100 mg
- J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7507 — Tacrolimus, immediate release, oral, 1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7510 — Prednisolone oral, per 5 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512 — Prednisone, immediate release or delayed release, oral, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7508
- Watch J7508 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7508
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.